Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration
Open Access
- 26 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0156542
Abstract
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is necessary for photoreceptors to generate an important lipid component of their membranes. The absence of LPCAT1 results in early and rapid rod and cone degeneration. Retinal degeneration 11 (rd11) mice carry a mutation in the Lpcat1 gene, and are an excellent model of early-onset rapid retinal degeneration (RD). To date, no reports have documented gene therapy administration in the rd11 mouse model at different ages. In this study, the AAV8 (Y733F)-smCBA-Lpcat1 vector was subretinally injected at postnatal day (P) 10, 14, 18, or 22. Four months after injection, immunohistochemistry and analysis of retinal morphology showed that treatment at P10 rescued about 82% of the wild-type retinal thickness. However, the diffusion of the vector and the resulting rescue were limited to an area around the injection site that was only 31% of the total retinal area. Injection at P14 resulted in vector diffusion that covered approximately 84% of the retina, and we found that gene therapy was more effective against RD when exposure to light was limited before and after treatment. We observed long-term preservation of electroretinogram (ERG) responses, and preservation of retinal structure, indicating that early treatment followed by limited light exposure can improve gene therapy effectiveness for the eyes of rd11 mice. Importantly, delayed treatment still partially preserved M-cones, but not S-cones, and M-cones in the rd11 retina appeared to have a longer window of opportunity for effective preservation with gene therapy. These results provide important information regarding the effects of subretinal gene therapy in the mouse model of LPCAT1-deficiency.Keywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LY15H120002)
- General Scientific Research Program from Zhejiang Provincial Education Commission of China (Y201431063)
- Wenzhou Municipal Science and Technology Bureau (Y20140352)
- Wenzhou Municipal Science and Technology Bureau (Y20140355)
- National Natural Science Foundation of China (81371060)
This publication has 46 references indexed in Scilit:
- AAV Mediated GDNF Secretion From Retinal Glia Slows Down Retinal Degeneration in a Rat Model of Retinitis PigmentosaMolecular Therapy, 2011
- Long-term Retinal Function and Structure Rescue Using Capsid Mutant AAV8 Vector in the rd10 Mouse, a Model of Recessive Retinitis PigmentosaMolecular Therapy, 2011
- Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 miceProceedings of the National Academy of Sciences, 2010
- Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiencyGene Therapy, 2010
- RETRACTED ARTICLE: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsGene Therapy, 2009
- Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouseGene Therapy, 2009
- High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype VectorsMolecular Therapy, 2009
- Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 2008
- Light-Driven Cone Arrestin Translocation in Cones of Postnatal Guanylate Cyclase-1 Knockout Mouse Retina Treated with AAV-GC1Investigative Ophthalmology & Visual Science, 2006
- Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cellsProceedings of the National Academy of Sciences, 2006